The latest data for 2024 shows that the United States leads in global biotechnology R&D intensity in the business sector with a value of 0.19, demonstrating a notable increase of 8.58% over the previous year. Germany and Japan follow with values of 0.09 and 0.077, respectively, with Japan experiencing a significant YoY growth of 23.57%. Meanwhile, countries like the Czech Republic and Canada also show considerable improvements of 9.29% and 14.67%, respectively. On the other hand, Switzerland and Denmark report slight declines in their R&D intensity values.
Future trends to watch for include the potential for emerging markets such as Poland, with a remarkable 17.09% YoY growth, to become significant players in biotechnology R&D. Additionally, consistent growth in countries like the United States, Japan, and the Czech Republic suggests a continued focus on advancing biotechnology. Observing the interplay of stable growth in Germany and new market entrances will be crucial in shaping the global landscape of biotechnology R&D.
Top countries in Biotechnology R&D Intensity in the Business Sector by Country
| # | 10 Countries | Percent of Value Added in Industry | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 0.19 | 2023 | +2.02% | +8.58% | View data |
| 2 | 2 Germany | 0.09 | 2023 | -0.046% | View data | |
| 3 | 3 Japan | 0.077 | 2023 | +18.63% | +23.57% | View data |
| 4 | 4 Ireland | 0.064 | 2023 | +6.28% | +1.47% | View data |
| 5 | 5 Czech Republic | 0.059 | 2023 | +6.69% | +9.29% | View data |
| 6 | 6 Switzerland | 0.031 | 2023 | -3.73% | -2.58% | View data |
| 7 | 7 Lithuania | 0.027 | 2023 | +41.72% | View data | |
| 8 | 8 Norway | 0.021 | 2023 | +9.39% | +5.27% | View data |
| 9 | 9 Italy | 0.015 | 2023 | -1.07% | +2.83% | View data |
| 10 | 10 Canada | 0.008 | 2023 | +10.16% | +14.67% | View data |
